This work was supported by the grants from the National Natural Science Foundation of China(Nos.82271460 and U1804197);the Research Foundation of Henan Province(Nos.202300410308 and HNGD2022067);the National High-End Foreign Expert Recruitment Plan of China(No.G2022026006L);the Research Foundation of Xinxiang Medical University(Nos.XYBSKYZZ505319 and XYBSKYZZ201626).
Previous studies have shown that puerarin plays a key role in protecting humans and animals from cardiovascular diseases.The exact mechanism of the therapeutic effect of puerarin on various cardiovascular diseases(pro...
supported by the National key R&D Program of China(2021YFA0804904);the National Natural Science Foundation of China(22107030);the Chinese Postdoctoral Science Foundation(2020M681211);the Shanghai Morning Light Program(20CG36,China);the Shanghai Frontier Science Center of Optogenetic Techniques for Cell Metabolism(2021 Sci&Tech 03-28,China);the Innovative Research Team of High-level Local Universities in Shanghai(SHSMU-ZDCX20212702,China);the Chinese Special Fund for State Key Laboratory of Bioreactor Engineering(2060204)。
Sodium-glucose cotransporter 2(SGLT2)inhibitors have been reapproved for heart failure(HF)therapy in patients with and without diabetes.However,the initial glucose-lowering indication of SGLT2i has impeded their uses ...
This study was supported by the National Natural Science Foundation of China(81600341);the Medical Health Science and Technology Project of Zhejiang Province(2021RC091);the Natural Science Foundation of Zhejiang Province(LQ15H020005);Wenzhou Science Technology Bureau Foundation(Y20190616);Zhejiang Provincial Science and Technology Innovation Program(New Young Talent Program)for College Students(2021R413084).
Obesity is an important independent risk factor for cardiovascular diseases,remaining an important health concern worldwide.Evidence shows that saturated fatty acid-induced inflammation in cardiomyocytes contributes t...
Y Xiang received support from the National Key Research and Development Program of China(2017YFC1700402);National Outstanding Youth Science Fund Project of National Natural Science Foundation of China(81822048 and 81770256);Fund of Shanghai Pudong New Area(PDZY-2018-0603).
Sodium-glucose cotransporter 2(SGLT2)inhibitors reduce cardiovascular mortality in patients with diabetes mellitus but the protective mechanism remains elusive.Here we demonstrated that the SGLT2 inhibitor,Empaglifloz...